LEWIS ALAN 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Aug 30, 2018
Insider Transaction Report
Form 4
LEWIS ALAN
Director
Transactions
- Exercise/Conversion
Stock Option (Right to buy Common Stock)
2018-08-28−7,500→ 0 totalExercise: $14.39From: 2009-11-12Exp: 2019-05-11→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2018-08-28$14.39/sh+7,500$107,925→ 28,660 total - Sale
Common Stock
2018-08-28$99.11/sh−7,300$723,503→ 21,360 total - Sale
Common Stock
2018-08-28$99.12/sh−200$19,824→ 21,160 total
Footnotes (1)
- [F1]Reflects the number of options outstanding after the transactions from this specific stock option grant.